Clinical Trial Update: Calcium Sulfate Spacer in Open Tibia Fractures [Phase 4]

View source ↗

Summary

Phase 4 trial update for calcium sulfate spacer in open tibia fractures with sub-segmental bone loss; study terminated with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open Tibia Fracture with Sub-segmental Bone Loss

Drugs mentioned

• calcium sulfate spacer (calcium sulfate spacer)

Snippet

Sponsor: University of Washington | Conditions: Open tíbia Fracture With Sub-segmental Bone Loss | Phase 4 | Status: TERMINATED | Results posted: 2023-02-10